Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumorsReportar como inadecuado




Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumors - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cancer

, 10:98

First Online: 16 March 2010Received: 15 February 2009Accepted: 16 March 2010DOI: 10.1186-1471-2407-10-98

Cite this article as: Li, Z., Chen, B., Wu, Y. et al. BMC Cancer 2010 10: 98. doi:10.1186-1471-2407-10-98

Abstract

BackgroundBeclin 1, an important autophagy-related protein in human cells, is involved in cell death and cell survival. Beclin 1 mapped to human chromosome 17q21. It is widely expressed in normal mammary epithelial cells. Although down-regulated expression with mono-allelic deletions of beclin 1 gene was frequently observed in breast tumors, whether there was other regulatory mechanism of beclin 1 was to be investigated. We studied the expression of beclin 1 and explored the possible regulatory mechanisms on its expression in breast tumors.

Methods20 pairs of tumors and adjacent normal tissues from patients with sporadic breast invasive ductal cancer IDCs were collected. The mRNA expression of beclin 1 was detected by real-time quantitative RT-PCR. Loss of heterozygosity LOH was determined by real-time quantitative PCR and microsatellite methods. The protein expression of beclin 1, p53, BRCA1 and BRCA2 was assessed by immunohistochemistry. CpG islands in 5- genomic region of beclin 1 gene were identified using MethylPrimer Program. Sodium bisulfite sequencing was used in examining the methylation status of each CpG island.

ResultsDecreased beclin 1 mRNA expression was detected in 70% of the breast tumors, and the protein levels were co-related to the mRNA levels. Expression of beclin 1 mRNA was demonstrated to be much higher in the BRCA1 positive tumors than that in the BRCA1 negative ones. Loss of heterozygosity was detected in more than 45% of the breast tumors, and a dense cluster of CpG islands was found from the 5- end to the intron 2 of the beclin 1 gene. Methylation analysis showed that the promoter and the intron 2 of beclin 1 were aberrantly methylated in the tumors with decreased expression.

ConclusionsThese data indicated that LOH and aberrant DNA methylation might be the possible reasons of the decreased expression of beclin 1 in the breast tumors. The findings here shed some new light on the regulatory mechanisms of beclin 1 in breast cancer.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2407-10-98 contains supplementary material, which is available to authorized users.

Zidong Li, Bo Chen contributed equally to this work.

Download fulltext PDF



Autor: Zidong Li - Bo Chen - Yiqing Wu - Feng Jin - Yongjing Xia - Xiangjun Liu

Fuente: https://link.springer.com/



DESCARGAR PDF




Documentos relacionados